Embolic stroke and Weakness

Summary:

Weakness is found among people with Embolic stroke, especially for people who are male, 60+ old.

The study analyzes which people have Weakness with Embolic stroke. It is created by eHealthMe based on reports of 11 people who have Embolic stroke from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Embolic stroke?

Embolic stroke (stroke due to obstruction due to an embolus) is found to be associated with 365 drugs and 542 conditions by eHealthMe. Check the latest studies of Embolic stroke.

What is Weakness?

Weakness is found to be associated with 3,639 drugs and 6,617 conditions by eHealthMe. Check the latest studies of Weakness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 03, 2026

11 people who have Embolic Stroke and Weakness are studied.

Would you have Weakness when you have Embolic stroke?

Gender of people who have Embolic Stroke and experienced Weakness *:

female: 45.45 %
male: 54.55 %

Age of people who have Embolic Stroke and experienced Weakness *:

Common co-existing conditions for these people *:

High Blood Pressure: 5 people, 45.45%
Muscle Spasms (muscle contraction): 3 people, 27.27%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 18.18%
Insomnia (sleeplessness): 2 people, 18.18%
Vitamin D Decreased: 1 person, 9.09%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 9.09%
Drowsiness: 1 person, 9.09%
Dehydration (dryness resulting from the removal of water): 1 person, 9.09%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 9.09%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 9.09%

Common drugs taken by these people *:

Aspirin: 3 people, 27.27%
Eliquis: 3 people, 27.27%
Benadryl: 2 people, 18.18%
Xarelto: 2 people, 18.18%
Vitamin D3: 2 people, 18.18%
Plavix: 2 people, 18.18%
Tylenol: 2 people, 18.18%
Heparin: 2 people, 18.18%
Breo Ellipta: 1 person, 9.09%
Candesartan Cilexetil And Hydrochlorothiazide: 1 person, 9.09%

Common symptoms for these people *:

International Normalised Ratio Decreased: 2 people, 18.18%
Gait Disturbance: 2 people, 18.18%
Cerebral Ischaemia (insufficient blood flow to the brain to meet metabolic demand): 2 people, 18.18%
Fatigue (feeling of tiredness): 2 people, 18.18%
Overdose: 2 people, 18.18%
Dysstasia (difficulty in standing): 1 person, 9.09%
Heart Rate Increased: 1 person, 9.09%
Haemorrhagic Stroke (stroke caused by the rupture of a blood vessel in the brain): 1 person, 9.09%
Haemorrhage Intracranial (bleeding within the skull): 1 person, 9.09%
Haemoglobin Decreased: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Weakness?

- Check whether Weakness is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Embolic stroke (4,762 reports)
Weakness (586,876 reports)

All the drugs that are associated with Weakness:

Weakness (3,639 drugs)

All the conditions that are associated with Weakness:

Weakness (6,617 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Weakness and Embolic stroke, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.